Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Cash from Operations (2014 - 2023)

Mesoblast (MESO) posted Cash from Operations of 16278000.0 for Q2 2023, little changed sequentially from 16250000.0 in Q1 2023, and down 17.16% YoY from 19649568.38 in Q2 2022.

Analysis

Mesoblast (MESO) Cash from Operations (2014 - 2023) Analysis & Trends

Mesoblast has reported Cash from Operations for 8 years, with the latest figure at 16278000.0 in Q2 2023.

  • Quarterly Cash from Operations fell 17.16% year-over-year to 16278000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 63269000.0 (up 3.82% YoY) and the FY2025 annual result came in at 50000000.0, down 3.18% from the prior year.
  • Cash from Operations was little changed at 16278000.0 in Q2 2023 per MESO's latest filing, from 16250000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 1330000.0 in Q4 2019 and troughed at 30580000.0 in Q4 2020.
  • A 5-year average of 17882333.33 and a median of 17326500.0 in 2021 frame the typical range for Cash from Operations.
  • The sharpest annual moves came in 2020 and 2021: Cash from Operations plunged 2199.25% in 2020, then surged 40.42% in 2021.
  • Over 5 years, Cash from Operations stood at 1330000.0 in 2019, then slumped by 2199.25% to 30580000.0 in 2020, then surged by 40.42% to 18219000.0 in 2021, then climbed by 9.69% to 16454000.0 in 2022, then increased by 1.07% to 16278000.0 in 2023.
  • According to Business Quant data, Cash from Operations over the past three periods registered 16278000.0, 16250000.0, and 16454000.0 for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 813.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -526.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -387.32 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 462.82 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 326.72 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 728.46 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -88.83 Mn
10 Mesoblast 2.24 Bn 2.14 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 110.26 Mn
Mar 31, 2023 -77.73 Mn
Dec 31, 2022 16.45 Mn
Sep 30, 2022 14.29 Mn
Jun 30, 2022 -13.89 Mn
Mar 31, 2022 -15.47 Mn
Dec 31, 2021 -18.22 Mn
Sep 30, 2021 18.20 Mn
Jun 30, 2021 -18.92 Mn
Mar 31, 2021 -24.47 Mn
Dec 31, 2020 -30.58 Mn
Sep 30, 2020 -28.17 Mn
Mar 31, 2020 -36.78 Mn
Dec 31, 2019 -16.89 Mn
Sep 30, 2019 -15.56 Mn
Mar 31, 2019 -21.19 Mn
Dec 31, 2018 -1.96 Mn
Sep 30, 2018 -19.54 Mn
Jun 30, 2018 -20.19 Mn
Mar 31, 2018 -19.60 Mn